C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy

by Daniel Martin, Daniel Martin, Franz Rödel, Franz Rödel, Franz Rödel, Franz Rödel, Panagiotis Balermpas, Panagiotis Balermpas, Ria Winkelmann, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas, Claus Rödel, Claus Rödel, Claus Rödel, Claus Rödel
Published 2019-11-01

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma

by Daniel Martin, Daniel Martin, Daniel Martin, Daniel Martin, Jens von der Grün, Jens von der Grün, Jens von der Grün, Claus Rödel, Claus Rödel, Claus Rödel, Claus Rödel, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas
Published 2020-08-01

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer

by Daniel Martin, Franz Rödel, Franz Rödel, Franz Rödel, Ria Winkelmann, Panagiotis Balermpas, Panagiotis Balermpas, Panagiotis Balermpas, Claus Rödel, Claus Rödel, Claus Rödel, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas
Published 2017-09-01

Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions

by Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, Emmanouil Fokas, Franz Rödel
Published 2021-02-01

Management of anal cancer patients – a pattern of care analysis in German-speaking countries

by Daniel Martin, Jens von der Grün, Claus Rödel, Emmanouil Fokas
Published 2020-05-01

Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma

by Jens von der Grün, Ria Winkelmann, Markus Meissner, Ulrike Wieland, Steffi Silling, Daniel Martin, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas, Claus Rödel, Claus Rödel, Claus Rödel, Franz Rödel, Franz Rödel, Franz Rödel, Panagiotis Balermpas, Panagiotis Balermpas, Panagiotis Balermpas, Panagiotis Balermpas
Published 2019-01-01

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Bra...

by Max Fleischmann, Daniel Martin, Samuel Peña-Llopis, Samuel Peña-Llopis, Samuel Peña-Llopis, Julius Oppermann, Jens von der Grün, Markus Diefenhardt, Georgios Chatzikonstantinou, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas, Emmanouil Fokas, Claus Rödel, Claus Rödel, Claus Rödel, Claus Rödel, Klaus Strebhardt, Klaus Strebhardt, Klaus Strebhardt, Sven Becker, Franz Rödel, Franz Rödel, Franz Rödel, Franz Rödel, Nikolaos Tselis
Published 2019-08-01

Single-shot bevacizumab for cerebral radiation injury

by Martin Voss, Katharina J. Wenger, Emmanouil Fokas, Marie-Thérèse Forster, Joachim P. Steinbach, Michael W. Ronellenfitsch
Published 2021-02-01

Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1

by Isabel Freund, Stephanie Hehlgans, Daniel Martin, Michael Ensminger, Emmanouil Fokas, Claus Rödel, Markus Löbrich, Franz Rödel
Published 2020-05-01

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?

by Jens von der Grün, Franz Rödel, Christian Brandts, Emmanouil Fokas, Matthias Guckenberger, Claus Rödel, Panagiotis Balermpas
Published 2019-04-01

Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy

by Panagiotis Balermpas, Daniel Martin, Ulrike Wieland, Margret Rave-Fränk, Klaus Strebhardt, Claus Rödel, Emmanouil Fokas, Franz Rödel
Published 2017-03-01

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab

by Neel Patel, Sarah Able, Danny Allen, Emmanouil Fokas, Bart Cornelissen, Fergus V. Gleeson, Adrian L. Harris, Katherine A. Vallis
Published 2017-05-01

Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial

by Katharina J. Wenger, Marlies Wagner, Patrick N. Harter, Kea Franz, Jörg Bojunga, Emmanouil Fokas, Detlef Imhoff, Claus Rödel, Johannes Rieger, Elke Hattingen, Joachim P. Steinbach, Ulrich Pilatus, Martin Voss
Published 2020-11-01

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia

by Thomas M. Ashton, Emmanouil Fokas, Leoni A. Kunz-Schughart, Lisa K. Folkes, Selvakumar Anbalagan, Melanie Huether, Catherine J. Kelly, Giacomo Pirovano, Francesca M. Buffa, Ester M. Hammond, Michael Stratford, Ruth J. Muschel, Geoff S. Higgins, William Gillies McKenna
Published 2016-07-01

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial

by Daniel Martin, Panagiotis Balermpas, Johannes Gollrad, Christian Weiß, Chiara Valentini, Martin Stuschke, Henning Schäfer, Christoph Henkenberens, Jürgen Debus, David Krug, Thomas Kuhnt, Thomas Brunner, Tilman Bostel, Rita Engenhart-Cabillic, Ursula Nestle, Stephanie E. Combs, Claus Belka, Matthias Hautmann, Guido Hildebrandt, Cihan Gani, Bülent Polat, Claus Rödel, Emmanouil Fokas
Published 2020-07-01

An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.

by Veerle Kersemans, John S Beech, Stuart Gilchrist, Paul Kinchesh, Philip D Allen, James Thompson, Ana L Gomes, Zenobia D'Costa, Luke Bird, Iain D C Tullis, Robert G Newman, Aurelien Corroyer-Dulmont, Nadia Falzone, Abul Azad, Katherine A Vallis, Owen J Sansom, Ruth J Muschel, Borivoj Vojnovic, Mark A Hill, Emmanouil Fokas, Sean C Smart
Published 2017-01-01